Suvretta Capital Management 13F holdings, Q4 2022
Holdings as of December 31, 2022 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 89 US equity positions worth $2.4bn in its Q4 2022 13F filing. The largest position was UNH at 5.7% of the reported book, followed by UNP and OTIS. Against the Q3 2022 filing, it opened 17 new positions, added to 18 and reduced 10 among the top 50 holdings.
What did Suvretta Capital Management own in Q4 2022? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2022 |
|---|---|---|---|---|---|---|---|
| 1 | UNH UNITEDHEALTH GROUP INC | Healthcare | 5.7% | $136.1m | 256,714 | 7% | added |
| 2 | UNP UNION PAC CORP | Industrials | 4.5% | $107.9m | 521,173 | -2% | reduced |
| 3 | OTIS OTIS WORLDWIDE CORP | Industrials | 4.3% | $101.6m | 1,297,480 | 0% | held |
| 4 | HORIZON THERAPEUTICS PUB L | 4.2% | $99.5m | 874,291 | 23% | added | |
| 5 | EL LAUDER ESTEE COS INC | Consumer Defensive | 4.2% | $98.9m | 398,506 | 8% | added |
| 6 | TPR TAPESTRY INC | Consumer Cyclical | 3.5% | $83.0m | 2,180,922 | 0% | held |
| 7 | KURA KURA ONCOLOGY INC | Healthcare | 3.3% | $79.1m | 6,376,815 | 57% | added |
| 8 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 3.3% | $78.1m | 1,625,685 | -32% | reduced |
| 9 | RPRX ROYALTY PHARMA PLC | Healthcare | 3.3% | $78.0m | 1,974,625 | 7% | added |
| 10 | ARCELLX INC | 3.1% | $72.8m | 2,350,333 | 4% | added | |
| 11 | NKE NIKE INC | Consumer Cyclical | 2.4% | $58.3m | 497,937 | – | new |
| 12 | CANADIAN PAC RY LTD | 2.4% | $57.1m | 765,840 | -1% | reduced | |
| 13 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 2.4% | $56.5m | 685,001 | – | new |
| 14 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 2.3% | $55.2m | 436,756 | -20% | reduced |
| 15 | INTRA-CELLULAR THERAPIES INC | 2.3% | $54.9m | 1,036,948 | 22% | added | |
| 16 | T AT&T INC | Communication Services | 2.3% | $54.3m | 2,951,900 | – | new |
| 17 | BHVN BIOHAVEN LTD | Healthcare | 2.2% | $53.4m | 3,848,938 | 6145% | added |
| 18 | XYZ BLOCK INC | Technology | 2.2% | $53.1m | 844,303 | 28% | added |
| 19 | CL COLGATE PALMOLIVE CO | Consumer Defensive | 2.1% | $50.8m | 644,580 | – | new |
| 20 | INSM INSMED INC | Healthcare | 2.1% | $50.4m | 2,520,901 | 105% | added |
| 21 | SCHW SCHWAB CHARLES CORP | Financial Services | 2.1% | $50.3m | 604,204 | – | new |
| 22 | FIS FIDELITY NATL INFORMATION SV | Technology | 2.0% | $47.0m | 693,005 | – | new |
| 23 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.9% | $45.0m | 5,565,099 | 11% | added |
| 24 | SBUX STARBUCKS CORP | Consumer Cyclical | 1.9% | $44.4m | 448,041 | – | new |
| 25 | DG DOLLAR GEN CORP NEW | Consumer Defensive | 1.8% | $42.8m | 173,850 | – | new |
| 26 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.6% | $37.9m | 817,171 | 819% | added |
| 27 | 290A CHINOOK THERAPEUTICS INC | 1.6% | $37.9m | 1,444,830 | 4% | added | |
| 28 | CEG CONSTELLATION ENERGY CORP | Utilities | 1.6% | $37.2m | 431,969 | – | new |
| 29 | 430 TERNS PHARMACEUTICALS INC | 1.5% | $35.1m | 3,448,275 | – | new | |
| 30 | AMD ADVANCED MICRO DEVICES INC | Technology | 1.3% | $31.3m | 483,756 | – | new |
| 31 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.3% | $31.1m | 4,274,803 | 21% | added |
| 32 | XLE SELECT SECTOR SPDR TR | 1.3% | $30.0m | 342,570 | – | new | |
| 33 | META META PLATFORMS INC | Communication Services | 1.2% | $29.6m | 246,259 | -51% | reduced |
| 34 | ORCL ORACLE CORP | Technology | 1.2% | $29.3m | 358,313 | – | new |
| 35 | KEZAR LIFE SCIENCES INC | 1.0% | $24.7m | 3,504,264 | 7% | added | |
| 36 | GFL GFL ENVIRONMENTAL INC | Industrials | 0.9% | $22.0m | 753,818 | 0% | held |
| 37 | PROK PROKIDNEY CORP | 0.9% | $21.9m | 3,193,175 | 0% | held | |
| 38 | MCK MCKESSON CORP | Healthcare | 0.9% | $21.8m | 58,108 | -45% | reduced |
| 39 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.9% | $20.9m | 1,811,396 | -3% | reduced |
| 40 | COR AMERISOURCEBERGEN CORP | Healthcare | 0.9% | $20.7m | 124,658 | -64% | reduced |
| 41 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.8% | $19.3m | 685,772 | -29% | reduced |
| 42 | MARINUS PHARMACEUTICALS INC | 0.8% | $19.2m | 4,822,995 | 36% | added | |
| 43 | POINT BIOPHARMA GLOBAL INC | 0.8% | $19.2m | 2,627,000 | 13% | added | |
| 44 | DISCOVER FINL SVCS | 0.7% | $16.3m | 166,809 | – | new | |
| 45 | ELV ELEVANCE HEALTH INC | Healthcare | 0.6% | $14.9m | 28,971 | – | new |
| 46 | NVDA NVIDIA CORPORATION | Technology | 0.5% | $12.8m | 87,358 | – | new |
| 47 | PROTHENA CORP PLC | 0.5% | $12.4m | 206,448 | -35% | reduced | |
| 48 | ROST ROSS STORES INC | Consumer Cyclical | 0.5% | $12.2m | 105,040 | – | new |
| 49 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.5% | $11.7m | 3,347,897 | 4% | added |
| 50 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.5% | $11.2m | 1,902,643 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.